These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12180540)

  • 1. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
    Kaul G; Amiji M
    Pharm Res; 2002 Jul; 19(7):1061-7. PubMed ID: 12180540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.
    Potineni A; Lynn DM; Langer R; Amiji MM
    J Control Release; 2003 Jan; 86(2-3):223-34. PubMed ID: 12526819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model.
    Kaul G; Amiji M
    J Drug Target; 2004; 12(9-10):585-91. PubMed ID: 15621684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.
    Kaul G; Amiji M
    J Pharm Sci; 2005 Jan; 94(1):184-98. PubMed ID: 15761942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.
    Kaul G; Amiji M
    Pharm Res; 2005 Jun; 22(6):951-61. PubMed ID: 15948039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.
    Kommareddy S; Amiji M
    Nanomedicine; 2007 Mar; 3(1):32-42. PubMed ID: 17379167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.
    Kommareddy S; Amiji M
    J Pharm Sci; 2007 Feb; 96(2):397-407. PubMed ID: 17075865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses.
    Madan J; Dhiman N; Sardana S; Aneja R; Chandra R; Katyal A
    Anticancer Drugs; 2011 Jul; 22(6):543-55. PubMed ID: 21471809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
    Shenoy D; Little S; Langer R; Amiji M
    Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen.
    Chawla JS; Amiji MM
    Int J Pharm; 2002 Dec; 249(1-2):127-38. PubMed ID: 12433441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS.
    Shah LK; Amiji MM
    Pharm Res; 2006 Nov; 23(11):2638-45. PubMed ID: 16969696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and physical characterization of poly(ethylene glycol)-gelatin conjugates.
    Kushibiki T; Matsuoka H; Tabata Y
    Biomacromolecules; 2004; 5(1):202-8. PubMed ID: 14715027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on Tat peptide-polyethylene glycol modified gelatin-siloxane nanoparticles across the blood-brain barrier].
    Tian X; Wei F; Lin X; Feng W; Wang P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):486-90, 500. PubMed ID: 22826945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.